Keyera resumed with an Outperform at Raymond James

Raymond James analyst Michael Barth resumed coverage of Keyera with an Outperform rating and C$47 price target Valuation appears reasonable for the business, which has high quality cash flows, exposure to important macro tailwinds, spare capacity in prolific producing regions, and a very strong balance sheet, the analyst tells investors in a research note.